UBE2I and cancer: This study highlights the need for not only frequent breast screening and, use of digital mammography but also screening for potential mechanism-based biomarkers (like Ubc9, SIRT-1, β-catenin, etc.)that can predict TNBC early in women with high mammography density and BRCA1 mutation thus reducing the mortality associated with these aggressive cancers leading to health equity.